EUVIMEDEUVIMED entdecken
Crossref

Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement

Xu Hua Gong, Ming Xuan Feng, Zhi Guo Zhuang, Yun Qi Yan, Li Wang, Hai Nan Ren, Yi Zhu, Yang Song iD, Li Jun Qian iD, Jian Rong Xu, Yan Zhou, Qiang Xia

Journal of Magnetic Resonance Imaging · 2024

DOI: 10.1002/jmri.28848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Xu Hua Gong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Hepatoblastoma, Liver Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The assessment of resectability after neoadjuvant chemotherapy of hepatoblastoma is dependent on Post‐Treatment EXTENT of Disease (POSTTEXT) staging and its annotation factors P (portal venous involvement) and V (hepatic venous/inferior vena cava [IVC] involvement), but MR performance in assessing them remains unclear.

Purpose

To assess the diagnostic performance of contrast‐enhanced MR imaging for preoperative POSTTEXT staging and diagnosing vascular involvement in terms of annotation factors P and V in pediatric hepatoblastoma following neoadjuvant chemotherapy. Study Type Retrospective. Subjects Thirty‐five consecutive patients (17 males, median age, 24 months; age range, 6–98 months) with proven hepatoblastoma underwent preoperative MR imaging following neoadjuvant chemotherapy. Field Strength/Sequence 3.0 T; T2 ‐weighted imaging ( T2WI ), T2WI with fat suppression, diffusion weighted imaging, radial stack‐of‐the‐star/Cartesian 3D Dixon T1 ‐weighted gradient echo imaging. Assessment Three radiologists independently assessed the POSTTEXT stages and annotation factors P and V based on the 2017 PRE/POSTTEXT system. The sensitivities and specificities were calculated for 1) diagnosing each POSTTEXT stage; 2) discrimination of stages III and IV (advanced) from those stages I and II (non‐advanced) hepatoblastomas; and 3) annotation factors P and V. The combination of pathologic findings and surgical records served as the reference standard. Statistical Tests Sensitivity, specificity, Fleiss kappa test.

Results

The sensitivity and specificity ranges for discriminating advanced from non‐advanced hepatoblastomas were 73.3%–80.0% and 80.0%–90.0%, respectively. For annotation factor P, they were 66.7%–100.0% and 90.6%, respectively. For factor V, they were 75.0% and 67.7%–83.9%, respectively. There was excellent, substantial, and moderate agreement on POSTTEXT staging (Fleiss kappa = 0.82), factors P (Fleiss kappa = 0.64), and factors V (Fleiss kappa = 0.60), respectively. Data Conclusion MR POSTTEXT provides reliable discrimination between advanced and non‐advanced tumors, and MR has moderate to excellent specificity at identifying portal venous and hepatic venous/IVC involvement. Evidence Level 3 Technical Efficacy Stage 3

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaLiver NeoplasmsMaleChildHumansChild, PreschoolInfantNeoadjuvant TherapyRetrospective StudiesMagnetic Resonance ImagingHepatic VeinsSensitivity and SpecificityNeoplasm Staging

Stichwörter der Autor:innen

POSTTEXThepatoblastomamagnetic resonance imagingresectability

Autor:innen und Institutionen

  • Radiology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China.
  • Liver Surgery, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China.
  • MR Scientific Marketing, Siemens Healthineers Co Ltd, Shanghai, China.

ORCID-Profile: Yang Song, Li Jun Qian

Zitieren

APA

Gong, X. H., Feng, M. X., Zhuang, Z. G., Yan, Y. Q., Wang, L., Ren, H. N., Zhu, Y., Song, Y., Qian, L. J., Xu, J. R., Zhou, Y., & Xia, Q. (2024). Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.28848

Vancouver

Gong XH, Feng MX, Zhuang ZG, Yan YQ, Wang L, Ren HN, et al. Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.28848

BibTeX
@article{Gong2024,
  author = {Gong, Xu Hua and Feng, Ming Xuan and Zhuang, Zhi Guo and Yan, Yun Qi and Wang, Li and Ren, Hai Nan and Zhu, Yi and Song, Yang and Qian, Li Jun and Xu, Jian Rong and Zhou, Yan and Xia, Qiang},
  title = {Pediatric Hepatoblastoma After Neoadjuvant Chemotherapy: Diagnostic Performance of MR in Staging POSTTEXT and Vascular Involvement},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2024},
  doi = {10.1002/jmri.28848}
}
Kostenlos starten →